
University of California, Davis
Duchenne muscular dystrophy, the most severe form of muscular dystrophy, is an inherited neuromuscular disorder with physical and often intellectual implications. It is the most common lethal genetic disorder. Duchenne muscular dystrophy (DMD) is caused by a mutation in the dystrophin gene located on the short arm of the X chromosome. The result is absent or very low content of dystrophin, the protein that normally provides the structure for cell membranes to adhere to cell material, thus keeping cells intact. Muscle cells eventually die without enough dystrophin. About 1/3 of cases are new mutations, while 2/3 are inherited.Lists below present:
These are the guidelines that are used to guide the care of those with Duchenne muscular dystrophy at the University of California, Davis.
|
Extreme deficiency of dystrophin |
|
Elevated levels of serum creatine kinase and other enzymes (diminish over time) |
|
Hypotonia |
|
Developmental delay, often delay in walking |
|
Waddling gait |
|
Diminished or absent patellar tendon reflexes |
|
Gower sign by age 5 to 8 |
|
Difficulty climbing stairs |
|
Clumsiness |
|
Hypertrophy of muscles, principally of calf |
|
Standing and walking on balls of feet |
|
Lordosis |
|
Tight heel cords |
|
Leg pain |
|
Contractures (beginning with ankles, hips and knees, then upper limbs) |
|
Progressive muscle weakness and atrophy (esp. central body muscles, not distal) |
|
Deteriorating lung function |
|
Loss of ambulation between age 9 and 14 |
|
Early death (average age 16; maximum 30s) |
|
Scoliosis (75-90% if wheelchair bound) |
|
Kyphosis |
|
Respiratory failure |
|
Pneumonia |
|
Cardiomyopathy |
|
Chronic cardiac failure (up to 50%) |
|
Mental retardation (25-30%), usually mild |
|
Gastrointestinal disorders (dysphagia, acute gastric dilation, megacolon, volvulus, cramping pain, malabsorption) |
|
Malignant hyperthermia or hypothermia |
|
Obesity |
The first section lists evalualtions grouped by the frequency with which they should be performed. Following these are recommendations based on the stage of disease.
Assessments by Frequency Administered |
|||||||||||||||||||||||||||||||
| Upon Diagnosis | |||||||||||||||||||||||||||||||
|
Perform complete physical and neurological exam to detect congenital anomalies |
|||||||||||||||||||||||||||||||
|
Review family medical history |
|||||||||||||||||||||||||||||||
|
Blood tests: chemistry and hematology |
|||||||||||||||||||||||||||||||
|
Measure creatine kinase levels with blood test |
|||||||||||||||||||||||||||||||
|
Confirm diagnosis with muscle biopsy |
|||||||||||||||||||||||||||||||
|
Assess muscle function |
|||||||||||||||||||||||||||||||
|
Genetic testing |
|||||||||||||||||||||||||||||||
|
Provide genetic counseling, including discussion of inheritance risk (or refer to genetic counselor who is knowledgeable regarding Duchenne Dystrophy) |
|||||||||||||||||||||||||||||||
|
Refer to early intervention programs and/or disability support groups |
|||||||||||||||||||||||||||||||
|
Discuss possibility of SSI enrollment |
|||||||||||||||||||||||||||||||
| Every 6 Months | |||||||||||||||||||||||||||||||
|
Assess muscle function |
|||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||
|
Monitor for muscle weakness and atrophy |
|||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||
|
Monitor for scoliosis |
|||||||||||||||||||||||||||||||
|
Refer to orthotist or orthopedic surgeon as needed |
|||||||||||||||||||||||||||||||
|
Discuss durable medical equipment options |
|||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||
| Annually | |||||||||||||||||||||||||||||||
|
Assess lung function annually |
|||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||
|
Consider noninvasive intermittent positive ventilation as needed (24 hour and nighttime), tracheostomy |
|||||||||||||||||||||||||||||||
|
Assess cardiac function annually (Older than age 10) |
|||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||
|
Assess spine / orthopedic problems. |
|||||||||||||||||||||||||||||||
| General | |||||||||||||||||||||||||||||||
|
Recommend daily stretching exercises |
|||||||||||||||||||||||||||||||
|
Recommend mild exercise or aquatic therapy as long as no pain or exhaustion is experienced |
|||||||||||||||||||||||||||||||
|
Refer for physical and occupational therapy evaluation as needed |
|||||||||||||||||||||||||||||||
|
Refer to nutritionist or registered dietician because of increased caloric requirements |
|||||||||||||||||||||||||||||||
|
Consider surgery to release contractures or fixation of joints |
|||||||||||||||||||||||||||||||
|
Recommend epidural anesthesia as an alternative to general anesthesia in surgery to prevent cardiorespiratory complications |
|||||||||||||||||||||||||||||||
|
Refer for psychological evaluation and assessment of cognitive function as needed |
|||||||||||||||||||||||||||||||
|
Refer to psychological counseling. Encourage children to be independent as much and as long as possible |
|||||||||||||||||||||||||||||||
|
Assess behavioral problems, cognitive issues, learning / school issues, speech evaluation and therapy. |
|||||||||||||||||||||||||||||||
Assessments by Stage of Disease |
|||||||||||||||||||||||||||||||
| Phase I: Transitional (6 to 12 years) | |||||||||||||||||||||||||||||||
|
Recommend daily strength and flexibility exercises (swimming, bicycling, gymnastics) |
|||||||||||||||||||||||||||||||
|
Recommend daily stretching exercises |
|||||||||||||||||||||||||||||||
|
Refer for occupational and physical therapy evaluation several times a year |
|||||||||||||||||||||||||||||||
|
Consider referral to an orthotist for leg braces and night splinting to increase flexibility |
|||||||||||||||||||||||||||||||
|
Monitor school progress |
|||||||||||||||||||||||||||||||
|
Recommend and arrange for dental care |
|||||||||||||||||||||||||||||||
| Phase II: Loss of Ambulation (9 to 14 years) | |||||||||||||||||||||||||||||||
|
Monitor progression of disease |
|||||||||||||||||||||||||||||||
|
Monitor for spinal / orthopedic problems |
|||||||||||||||||||||||||||||||
|
Range of Motion: possible surgical release of contractures |
|||||||||||||||||||||||||||||||
|
Spinal problems: x-ray every 6 months and DEXA annually: possible surgical release for joint fixation or spine stabilization. |
|||||||||||||||||||||||||||||||
|
Refer to a pulmonary specialist for respiratory therapy initial consultation |
|||||||||||||||||||||||||||||||
|
Develop a standing and/or walking regimen to promote lung function and delay progression of scoliosis |
|||||||||||||||||||||||||||||||
|
Continue ongoing occupational and physical therapy evaluations several times a year |
|||||||||||||||||||||||||||||||
|
Consider referral to an orthotist for ankle/foot orthoses or leg braces and night splinting to increase flexibility; wheelchair use to maintain mobility; or scoliosis orthoses to support spine |
|||||||||||||||||||||||||||||||
|
Consider spinal stabilization surgery (spinal fusion, Luque rods) |
|||||||||||||||||||||||||||||||
| Phase III: End Stage (15 years and over) | |||||||||||||||||||||||||||||||
|
Monitor progression of disease |
|||||||||||||||||||||||||||||||
|
Continue ongoing occupational and physical therapy evaluations several times a year |
|||||||||||||||||||||||||||||||
|
Consider referral to an orthotist for leg braces, night splinting, and powered wheelchair with appropriate seating |
|||||||||||||||||||||||||||||||
|
Consider swimming or stationary cycling for cardiac health |
|||||||||||||||||||||||||||||||
|
Discuss long-term financial plans |
|||||||||||||||||||||||||||||||
|
Discuss alternative community living resources |
|||||||||||||||||||||||||||||||
Possible Interventions |
|||||||||||||||||||||||||||||||
|
Long-term steroid therapy to improve muscle strength |
|||||||||||||||||||||||||||||||
|
Surgical correction of contractures; tenotomy of the Achilles tendon; posterior tibial-tendon transfer surgery |
|||||||||||||||||||||||||||||||
|
Low intensity, low frequency electrical stimulation |
|||||||||||||||||||||||||||||||
|
Gene therapy: (1) adenovirus-mediated dystrophin gene transfer; (2) upregulation of utrophin, a natural dystrophin analog (still being researched) |
|||||||||||||||||||||||||||||||
|
Myoblast transplantation to replace dystrophin (still being researched) |
|||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||
Common Side-effects of Long-term Steroid Therapy |
|||||||||||||||||||||||||||||||
|
Weight gain - measure with DEXA |
|||||||||||||||||||||||||||||||
|
Hypertension - measure vital signs |
|||||||||||||||||||||||||||||||
|
Gastrointestinal bleeding - perform lab chemistries |
|||||||||||||||||||||||||||||||
|
Immunosuppression |
|||||||||||||||||||||||||||||||
|
Fractures & osteoporosis - measure with DEXA |
September 2007